Established in 2013, this manufacturer specializes in oncology, focusing on the research, manufacturing, and marketing of high-quality specialty formulations. As a CTD dossier owner and manufacturer, it holds GMP certifications from international regulatory authorities, including USFDA, MHRA, and PIC/S, ensuring compliance with stringent quality standards. The manufacturer operates a state-of-the-art facility in Hyderabad, India, designed to meet global regulatory requirements. As a CTD dossier owner and manufacturer, its products are distributed worldwide. With a commitment to innovation and quality, the manufacturer aims to provide the best options to oncologists and their patients.

Established in 2018, this manufacturer specializes in oncology, anti-cancer, cytotoxic, critical-care, life-saving, and general injectables, as well as oral solids like tablets and capsules. As a CTD dossier owner and manufacturer, it exports products to over 30 countries across Asia, Africa, LATAM, CIS, MENA, and Europe. Operating under WHO-GMP and PIC/S certifications, the GMP manufacturer maintains advanced production lines for liquid injectables, lyophilized injectables, pre-filled syringes, tablets, and capsules. As a CTD dossier owner and manufacturer, it upholds stringent quality standards and regulatory compliance

Established in 2011, this Indian pharmaceutical manufacturer specializes in oncology medicines and antibiotics. As a CTD dossier owner and manufacturer, it holds WHO-cGMP and ISO 9001:2008 certifications, ensuring compliance with international quality standards. The company operates advanced manufacturing facilities in Baddi, Himachal Pradesh, producing a wide range of pharmaceutical formulations, including injectables (lyophilized and liquid), oral liquids, dry syrups, tablets, capsules, sachets, gels, dietary proteins, and food supplements. Its products are distributed across more than 15 countries, with a portfolio exceeding 500 approved products.